Wyeth CEO says industry's ED ads went overboard

Share this article:
Wyeth CEO Robert Essner told The Wall Street Journal that the industry went overboard with ED ads, but said critics are all wet: “There's a real war of information that's going on today, and I think we're in an environment where payers and the government would frankly love to be…the only ones who knew what the options were.”

Share this article:
close

Next Article in News

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.